Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials

Tyrosine kinase inhibitors (TKIs) have been improving the prognosis of patients with chronic myeloid leukemia (CML), but there are still large differences in survival among European countries. This raises questions on the added value of results from population-based studies, which use real-world dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vener, Claudia, Rossi, Silvia, Minicozzi, Pamela, Marcos-Gragera, Rafael, Poirel, Hélène A., Maynadié, Marc, Troussard, Xavier, Pravettoni, Gabriella, De Angelis, Roberta, Sant, Milena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333088/
https://www.ncbi.nlm.nih.gov/pubmed/35912208
http://dx.doi.org/10.3389/fonc.2022.892684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333088/
https://www.ncbi.nlm.nih.gov/pubmed/35912208
http://dx.doi.org/10.3389/fonc.2022.892684

Ejemplares similares